| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.21 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |